Temat: patient - Katalog OPAC zbiorów

Skocz do pozycji: 1.

Tytuł:: Severe gynaecomastia associated with spironolactone treatment in a patient with decompensated alcoholic liver cirrhosis - case report
Autorzy:: Schab, K.
Prystupa, A.
Mulawka, D.
Mulawka, P.
Powiązania:: https://bibliotekanauki.pl/articles/3042.pdf
Data publikacji:: 2015
Wydawca:: Instytut Medycyny Wsi
Tematy:: gynaecomastia
spironolactone
treatment
patient
alcoholic disease
liver cirrhosis
Opis:: Gynaecomastia is uni- or bilateral breast enlargement in males associated with benign hyperplasia of the glandular, fibrous and adipose tissue resulting from oestrogen-androgen imbalance. Asymptomatic gynaecomastia is a common finding in healthy male adults and does not have to be treated, while symptomatic gynaecomastia might be the symptoma of many pathological conditions and requires meticulous diagnosis and therapeutic management. The commonest causes of gynaecomastia in the Polish population include liver cirrhosis and drugs used to treat its complications. The current study presents the case of severe painless gynaecomastia in a patient with decompensated alcoholic liver cirrhosis, treated with spironolactone because of ascites. Breast enlargement assessed a IIb according to the Simon’s Scale or III according to the Cordova-Moschella classification, developed slowly over the two-year period of low-dose spironolactone therapy The course and dynamics of disease are described and the main mechanisms leading to its development discussed. The importance of effective treatment of patients with severe gynecomastia is emphasized as the disease may result in significant psychosocial problems.
Źródło:: Journal of Pre-Clinical and Clinical Research; 2015, 09, 1
1898-2395
Pojawia się w:: Journal of Pre-Clinical and Clinical Research
Dostawca treści:: Biblioteka Nauki

Artykuł

Zmień widok

na półce

Skocz do pozycji: 2.

Tytuł:: Paraneoplastic syndromes in daily clinical practice
Autorzy:: Wojtowicz, M.
Rekas-Wojcik, A.
Lipa, A.
Prystupa, A.
Dzida, G.
Powiązania:: https://bibliotekanauki.pl/articles/3530.pdf
Data publikacji:: 2014
Wydawca:: Instytut Medycyny Wsi
Tematy:: human disease
paraneoplastic syndrome
disease syndrome
clinical practice
cancer
patient
Opis:: Paraneoplastic syndromes consist of disorders that accompany benign and malignant tumours, but are not directly related to mass effects or invasion by the primary tumour or its metastases. The pathophysiology of mostly paraneoplastic syndromes is not well known. The usual mechanism of their development is the aberrant production of substances (protein hormones, hormone precursors or hormone-like substances) by tumour tissue or autoimmune disorder. The neurological paraneoplastic syndromes are autoimmune disorders that can affect almost any part of the nervous system. The endocrine paraneoplastic syndromes are often certain clinical syndromes like paraneoplastic hypercalcaemia or the aberrant production of hormones by cancers. Many haematologic conditions, including anaemia, leucocytosis, thrombocytopenia or thrombocytosis, coagulapathy have been reported in association with cancer. Also paraneoplastic rheumatic syndromes have been reported in association of cancer. Skin can be involved in cancer in different ways: by metastases, as a part of a genetic disorder with a cutaneous component in which there is an inherited predisposition to the later development of malignancy, as a part of an acquired syndrome due to the toxicity of a carcinogen that induces malignant change and accompanying skin changes, as a consequence of immunosuppression, or by the development of specific lesions that occur as a paraneoplastic syndromes The most frequently diagnosed dermatologic conditions include acrokeratosis paraneoplastica, Sweet’s syndrome and paraneoplastic pemphigus. The purpose of this article is to describe the most popular in internal clinical practice neurologic, endocrine, haematologic, rheumatologic and dermatologic paraneoplastic syndromes associated with cancer.
Źródło:: Journal of Pre-Clinical and Clinical Research; 2014, 08, 2
1898-2395
Pojawia się w:: Journal of Pre-Clinical and Clinical Research
Dostawca treści:: Biblioteka Nauki

Artykuł

Zmień widok

na półce

Skocz do pozycji: 3.

Tytuł:: Pictorial review of COVID-19 in the Lublin Region – Imaging disease progression with CXR and CT
Autorzy:: Kurys-Denis, E.
Podgorska, K.
Prystupa, A.
Powiązania:: https://bibliotekanauki.pl/articles/2098251.pdf
Data publikacji:: 2020
Wydawca:: Instytut Medycyny Wsi
Tematy:: COVID-19
pandemic
clinical symptom
diagnosis
treatment
monitoring
patient
diagnostic imaging
Opis:: Introduction. COVID-19 is a disease caused by SARS-Cov-2 that has reached the pandemic status and has infected in one year more than 62 million people. Clinical symptoms range from barely noticeable to very severe. It is crucial to recognize imaging patterns of COVID-19, allowing for better diagnosis and treatment. Diagnostic imaging is also essential in monitoring patients in the course of the disease. Objective. In our pictorial review we describe the most common pulmonary manifestations of COVID-19, and show the typical and non-typical features of COVID-19 encountered in our hospital in Lublin, Poland. Imaging the disease progression is also visualized to help realize how pulmonary changes occur over the time. State of knowledge and Conclusions. COVID-19 involves both lung parenchyma and interstitium and has multiple imaging features, varying form ground glass opacities (GGO), consolidations, reticular interstitial pattern, honeycombing or crazy- paving. Mediastinal and hilar lymph node enlargement or pleural effusion may appear, but are rare and atypical. GGO are located peripherally, bilaterally and predominantly in the lower lobes, and in the early stage are better seen on CT imaging. Progression of imaging findings take different times, with the peak of of imaging features appearing around 10–14 days after initial symptoms. While it is harder to discern subtle changes on CXR, progression can be very well monitored by his method. Final pulmonary consequences of the disease should be assessed with the use of CT.
Źródło:: Journal of Pre-Clinical and Clinical Research; 2021, 15, 1; 40-45
1898-2395
Pojawia się w:: Journal of Pre-Clinical and Clinical Research
Dostawca treści:: Biblioteka Nauki